| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pharmacology [D. K., V. S.] and Pathology [D. Ku.], Wayne State University, Detroit, Michigan 48201, and Department of Pharmacology [W. B.], St. Jude Children's Hospital, Memphis, Tennessee 38101
Fluorimetric techniques were used to examine accumulation of fluorescent probes by the P388 murine leukemia and an anthracycline-resistant subline, P388/Adriamycin(ADR), which expresses the multidrug-resistant phenotype. P388 could be differentiated from P388/ADR on the basis of fluorescence intensity measurements using 3 classes of cationic dyes that are sensitive to membrane potential differences: rhodamine esters, cyanines, and styrylpyridinium dyes. But fluorescence intensity differences were also observed with potential-insensitive dyes: zwitterionic rhodamines and an acridine orange derivative. In all cases, fluorescence intensity differences were caused by impaired dye accumulation, and could be eliminated by treatment of P388/ADR cells with verapamil. Moreover, fluorescence signals from 2 anionic potential-sensitive dyes, merocyanine 540 and a bis-oxonol, were identical in P388 and P388/ADR. None of these dyes could be used to delineate CCRF-CEM, a lymphoblastic leukemia of human origin from the CEM/VM-1 subline that exhibits a markedly atypical drug resistance pattern not based on an enhanced outward transport. But accumulation of both neutral and cationic dyes was impaired in CEM/VLB100, a subline of CCRF-CEM expressing mdr. These studies show that many cationic and neutral fluorescent probes are substrates for the enhanced outward drug transport system associated with P388/ADR cells, and cannot be used to probe membrane-potential differences in cells expressing the mdr phenotype. With several dyes, differences in fluorescence intensity were sufficient so that flow cytometry could be used to delineate P388 from P388/ADR and CCRF-CEM from CEM-VLB100. The latter technique may be useful for identifying malignant cell populations expressing multidrug resistance in patients with neoplastic disease.
1 This work was supported in part by Grants CA 23378, CA 40570, and CA 21765 from the National Cancer Institute, NIH, Department of Health and Human Services, and by a grant from the American Lebanese Associated Charities.
2 To whom requests for reprints should be addressed.
Received 2/22/91. Accepted 6/12/91.
This article has been cited by other articles:
![]() |
D. Becton, G. V. Dahl, Y. Ravindranath, M. N. Chang, F. G. Behm, S. C. Raimondi, D. R. Head, K. C. Stine, N. J. Lacayo, B. I. Sikic, et al. Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421 Blood, February 15, 2006; 107(4): 1315 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Crivellato, L. Candussio, A. M. Rosati, F. Bartoli-Klugmann, F. Mallardi, and G. Decorti The Fluorescent Probe Bodipy-FL-Verapamil Is a Substrate for Both P-glycoprotein and Multidrug Resistance-related Protein (MRP)-1 J. Histochem. Cytochem., May 1, 2002; 50(5): 731 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Kim, J. M. Dintaman, D. S. Waddell, and J. A. Silverman Saquinavir, an HIV Protease Inhibitor, Is Transported by P-Glycoprotein J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1439 - 1445. [Abstract] [Full Text] |
||||
![]() |
M. Kim, D. D. Cooper, S. F. Hayes, and G. J. Spangrude Rhodamine-123 Staining in Hematopoietic Stem Cells of Young Mice Indicates Mitochondrial Activation Rather Than Dye Efflux Blood, June 1, 1998; 91(11): 4106 - 4117. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Kunz-Schughart, R. C. Habbersett, and J. P. Freyer Mitochondrial function in oncogene-transfected rat fibroblasts isolated from multicellular spheroids Am J Physiol Cell Physiol, November 1, 1997; 273(5): C1487 - C1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kolaczkowski, M. van der Rest, A. Cybularz-Kolaczkowska, J.-P. Soumillion, W. N. Konings, and A. Goffeau Anticancer Drugs, Ionophoric Peptides, and Steroids as Substrates of the Yeast Multidrug Transporter Pdr5p J. Biol. Chem., December 6, 1996; 271(49): 31543 - 31548. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |